Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats

Endocrinology

Volumn 143, Issue 5, 2002, Pages 1625-1636

  Peleg, Sara ^a   Uskokovic, Milan ^b   Ahene, Ago ^b   Vickery, Brian ^b   Avnur, Zafrira ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALBINDIN; CALCITRIOL; CALCIUM; COLECALCIFEROL DERIVATIVE; GENE PRODUCT; GLOBIN MESSENGER RNA; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; OXYGENASE; RO 26 9228; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE STRUCTURE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; DRUG MECHANISM; DUODENUM MUCOSA; FEMALE; GENE EXPRESSION REGULATION; GROWTH STIMULATION; HYPERCALCEMIA; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; RNA BINDING; TRABECULAR BONE;

EID: 0036227148     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.5.8777     Document Type: Article

References (56)

1. Osteoporosis prevention, diagnosis, and therapy
2. How many women have osteoporosis now?
3. Bone mass measurements: Prediction of risk
4. Bone remodeling
5. Bone formation: Osteoblast cells lineage, growth factors, matrix proteins, and the mineralization process
6. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (calcitriol) for four years
7. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
8. 3 analogs
9. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor
10. 3 receptor
11. 3 analogs on clonal proliferation of human prostate cancer cell lines
12. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog
13. 3 analogue toward vitamin D receptor function
14. 3
15. Selective estrogen receptor modulation: A personal perspective
16. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-choroform extraction
17. 3 are associated with enhanced activation of the vitamin D receptor
18. 3 to its chick intestinal mucosa receptor using a hydroxyapatite batch assay
19. 3 into new metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8)
20. Renal and intestinal calcium transport: Roles of vitamin D and vitamin D-dependent calcium binding proteins
21. 2D and cAMP or PTH
22. 3 24-hydroxylase (CYP24) promoter
23. 3-response element in the 5′-flanking region of the rat calbindin D-9k gene
24. Transgenic analysis of the response of the rat calbindin-D 9k gene to vitamin D
25. Vitamin-D-dependent transcriptional regulation of the intestinal plasma membrane calcium pump
26. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon
27. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa
28. 3 24-hydroxylase): Implications for differing mechanisms of regulation and involvement of multiple factors
29. 3
30. 3
31. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression
32. 3 response elements in the human transforming growth factor β2 gene
33. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
34. On the mechanism for the selective action of vitamin D analogs
35. Pharmacokinetic studies of vitamin D analogues: Relationship to vitamin D binding protein (DBP)
36. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts
37. 3
38. 3-mediated regulation of transcellular calcium transport in caco-2 cells
39. Structure-function relationships in the vitamin D endocrine system
40. The 16-ene analogs of 1,25-dihydroxycholecalciferol synthesis and biological activity
41. The 16-ene vitamin D analogs
42. Analog metabolism
43. 3 analogues and their 20-epi homologues with the vitamin D receptor
44. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
45. 3, 17β-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro
46. 17β-oestradiol and 1α,25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1 β (IL-1β) production by peripheral blood mononuclear cells isolated from postmenopausal women
47. 3
48. 3 receptor
49. Vitamin D and the parathyroid gland
50. Vitamin D deficiency causes a selective reduction in deposition of transforming growth β in rat bone: Possible mechanisms for impaired osteoinduction
51. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine
52. 3 and its analogs
53. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
54. Comparative analyses of mechanistic differences among antiestrogens
55. Selective oestrogen receptor modulation: Molecular pharmacology for the millennium